Physician profile
Michael A Marano
NPI 1972569309
$893.12
in general payments reported to CMS, 2019-2025
7 companies · $35.43 in 2025
The $35.43 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $208 · 2022: $36.80 · 2023: $82.94 · 2024: $413 · 2025: $35.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Education: $13.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.74 |
| Education | $13.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $374.36 | 2019-2023 | Recell |
| Polynovo North America LLC | $235.26 | 2022-2024 | Novosorb Btm |
| Acera Surgical, INC. | $184.15 | 2024-2025 | Restrata Wound Matrix |
| Urgo Medical North America, LLC | $52.19 | 2024 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Bausch & Lomb Americas INC. | $16.79 | 2023 | Envista Mx60 Iol |
| Smith+Nephew, INC. | $16.67 | 2023 | Collagenase Santyl |
| Vericel Corporation | $13.70 | 2024 | Nexobrid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.